JHM Schellens

732 citations
16 papers · 626 indexed · h-index 12

JHM Schellens

16 papers receiving 607 citations

Peers

JHM Schellens
Comparison fields: 5 of 63
  • Oncology 448
  • Toxicology 45
  • Molecular Biology 412
  • Pathology and Forensic Medicine 78
  • Pharmacology 29
Replace Philippe Genne with:
Philippe Genne France
Sikic Bi United States
D Abigerges France
Yan‐jun Mi China
Maria A.J. van Eijndhoven Netherlands
Joseph A. Sinkule United States
Yasuyoshi Kawato Japan
Corbett Th
Jean-Pierre Bizzari France
Yang-Hui Huang Taiwan
JHM Schellens relative to Philippe Genne France Philippe Genne's profile →
Citations per field
00.5×1.5×2.3×
Philippe Genne · 1×
Citations per year

Countries citing papers authored by JHM Schellens

Since Specialization
Citations

This map shows the geographic impact of JHM Schellens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JHM Schellens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JHM Schellens more than expected).

Fields of papers citing papers by JHM Schellens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JHM Schellens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JHM Schellens. The network helps show where JHM Schellens may publish in the future.

Co-authorship network

The 25 scholars most cited alongside JHM Schellens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with JHM Schellens Line = papers co-authored together JHM Schellens links everyone, so they are left out of the graph.

All Works

16 of 16 papers shown
#Work
1 201212
2 20092
3 20089
4 200723
5 200024
6 19993
7 199818
8 199851
9 199724
10 1997120
11 1996113
12 1996122
13 199637
14 199610
15 199529
16 199429

About JHM Schellens

JHM Schellens is a scholar working on Family Practice, Oncology, Toxicology, Pathology and Forensic Medicine and Hematology, having authored 16 papers that have together received 626 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (8 papers), Neutropenia and Cancer Infections (4 papers), Lung Cancer Research Studies (4 papers), Chemotherapy-induced organ toxicity mitigation (4 papers), Cancer Treatment and Pharmacology (3 papers), Drug Transport and Resistance Mechanisms (2 papers), Pharmaceutical studies and practices (2 papers) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Oncology (448 citations), Toxicology (45 citations), Molecular Biology (412 citations), Pathology and Forensic Medicine (78 citations) and Pharmacology (29 citations). JHM Schellens has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Jaap Verweij, G. Stoter, M de Boer-Dennert, A.S.T. Planting, Jun Ma, G.J. Creemers, Hilde Rosing, Jos H. Beijnen, E. van Meerten and B. E. Davies. Their work appears in journals such as British Journal of Cancer, Clinical Pharmacology & Therapeutics, Anti-Cancer Drugs, Bioanalysis and Journal of Oncology Pharmacy Practice.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026